PTC Therapeutics Inc’s recently made public that its CHIEF EXECUTIVE OFFICER Klein Matthew B. unloaded Company’s shares for reported $32851.0 on Apr 17 ’24. In the deal valued at $25.14 per share,1,307 shares were sold. As a result of this transaction, Klein Matthew B. now holds 229,168 shares worth roughly $5.8 million.
Then, Pauwels Eric sold 787 shares, generating $19,781 in total proceeds. Upon selling the shares at $25.14, the CHIEF EXECUTIVE OFFICER now owns 67,694 shares.
Before that, Golden Lee Scott sold 526 shares. PTC Therapeutics Inc shares valued at $14,923 were divested by the EVP & CHIEF MEDICAL OFFICER at a price of $28.37 per share. As a result of the transaction, Golden Lee Scott now holds 59,988 shares, worth roughly $1.52 million.
Morgan Stanley downgraded its PTC Therapeutics Inc [PTCT] rating to an Underweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in early December with a ‘”an Overweight”‘ rating. Oppenheimer also remained covering PTCT and has increased its forecast on October 30, 2023 with a “an Outperform” recommendation from previously “Perform” rating. Citigroup revised its rating on October 27, 2023. It rated PTCT as “a Sell” which previously was an “a Neutral”.
Price Performance Review of PTCT
On Friday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock jump 2.55% to $25.32. Over the last five days, the stock has lost -4.16%. PTC Therapeutics Inc shares have fallen nearly -8.13% since the year began. Nevertheless, the stocks have fallen -52.41% over the past one year. While a 52-week high of $59.84 was reached on 03/01/24, a 52-week low of $17.53 was recorded on 02/13/24. SMA at 50 days reached $27.99, while 200 days put it at $29.06. A total of 3.93 million shares were traded, compared to the trading of 0.82 million shares in the previous session.
Levels Of Support And Resistance For PTCT Stock
The 24-hour chart illustrates a support level at 24.37, which if violated will result in even more drops to 23.42. On the upside, there is a resistance level at 25.91. A further resistance level may holdings at 26.50. The Relative Strength Index (RSI) on the 14-day chart is 38.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.79%. Stochastics %K at 12.00% indicates the stock is a buying.
